Upward view of modern glass and steel skyscrapers converging against a gray, overcast sky.

Defending "Experimental" Wound Care Products

A litigation framework for separating lawful coverage disputes from allegations of fraud.

Medicare contractors are denying wound care claims by labeling products "experimental" — often without any real legal basis. This white paper from Ron Chapman II gives wound care providers, manufacturers, and counsel a clear strategy for fighting these denials, protecting against recoupment, and staying ahead of federal scrutiny.

Chapman, Dowling & Mallek

Download Your Free White Paper

Enter your information below and we'll email you a copy of Defending "Experimental" Wound Care Products.

Disclaimer Agreement

Protect Your Reputation Before the Government Defines the Narrative

Federal investigations move quickly — and early decisions can have lasting consequences. If you believe you are under investigation or have been contacted by federal authorities, speaking with experienced federal defense counsel immediately can make a critical difference.

Speak directly with a federal attorney — available 24/7 for calls or texts.

Disclaimer Agreement